Latest Breaking News On - Federal comprehensive drug abuse prevention - Page 1 : comparemela.com
DEA reclassifying marijuana: What schedule 3 could mean
inquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.com Daily Mail and Mail on Sunday newspapers.
We need federal cannabis regulation
minnpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from minnpost.com Daily Mail and Mail on Sunday newspapers.
The War on Drugs turns 50 today
newsday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.com Daily Mail and Mail on Sunday newspapers.
Ketamine and non-label issues-Canna Law Blog™
A common question that arises in ketamine clinic transactions is whether clinics or doctors (collectively referred to as “healthcare providers” or “providers”) can use ketamine for off-label use or promotion. The short answer is yes, but pay attention to the following points, as described below. However, before reaching the answer, it is important to define the meaning of “off-label” use and whether the U.S. Food and Drug Administration (“FDA”) has jurisdiction over healthcare providers to enforce off-label promotions.
What is “non-label” use?
The term “off-label” refers to prescriptions for indications not listed on the drug label. The label must be approved by the FDA during the pre-market approval process and must contain certain information about the approved use.
Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities
- NetworkNewsWire Editorial Coverage
NEW YORK, May 20, 2021 /PRNewswire/ Before government legislation brought the world of psychedelic drug compounds to a halt, promising research was being done in the space. As researchers and scientists took closer looks at substances such as psilocybin, ketamine, DMT (dimethyltryptamine), LSD (lysergic acid diethylamide) and more, the potential for the compounds appeared to be widespread and even life-changing for many who struggled with notoriously difficult diseases such as depression, addiction, PTSD and more. And then the Federal Comprehensive Drug Abuse Prevention and Control Act of 1970, known as the Controlled Substance Act, took effect. For decades, the promise of these substances has remained ignored. However, with recent changes in legal guidelines and swings in public opinion, astute researchers - and companies - are showing renew